Chen, L-C <br/><br/>
Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Dec 2006 
 - 565-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>0269-4727 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2710.2006.00774.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Cyclooxygenase Inhibitors--adverse effects<br/>Humans<br/>Naproxen--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Risk<br/>Stroke--chemically induced